Insider Selling: Medidata Solutions Inc (MDSO) Director Sells $137,164.00 in Stock

Medidata Solutions Inc (NASDAQ:MDSO) Director Robert Taylor sold 2,120 shares of the business’s stock in a transaction that occurred on Monday, January 7th. The stock was sold at an average price of $64.70, for a total transaction of $137,164.00. Following the completion of the transaction, the director now owns 41,916 shares in the company, valued at approximately $2,711,965.20. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Medidata Solutions stock opened at $68.48 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.52 and a current ratio of 2.52. Medidata Solutions Inc has a 12-month low of $59.60 and a 12-month high of $88.87. The firm has a market cap of $4.13 billion, a P/E ratio of 70.29, a P/E/G ratio of 4.00 and a beta of 1.32.

Medidata Solutions (NASDAQ:MDSO) last released its earnings results on Thursday, October 18th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.36 by $0.06. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. The company had revenue of $163.41 million for the quarter, compared to the consensus estimate of $162.09 million. During the same quarter in the previous year, the company earned $0.33 EPS. Medidata Solutions’s quarterly revenue was up 17.6% compared to the same quarter last year. On average, equities research analysts expect that Medidata Solutions Inc will post 0.85 EPS for the current fiscal year.

A number of brokerages have recently issued reports on MDSO. Zacks Investment Research downgraded shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research report on Tuesday. BidaskClub downgraded shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research report on Monday. Piper Jaffray Companies dropped their price target on shares of Medidata Solutions to $83.00 and set an “overweight” rating on the stock in a research report on Friday, January 4th. Leerink Swann began coverage on shares of Medidata Solutions in a research report on Wednesday, January 2nd. They issued a “market perform” rating and a $70.00 price target on the stock. Finally, TheStreet downgraded shares of Medidata Solutions from a “b” rating to a “c+” rating in a research report on Thursday, December 20th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $82.82.

Institutional investors have recently added to or reduced their stakes in the stock. Man Group plc acquired a new position in shares of Medidata Solutions during the 3rd quarter valued at $205,000. First Republic Investment Management Inc. bought a new stake in Medidata Solutions during the 2nd quarter valued at $242,000. Quantbot Technologies LP bought a new stake in Medidata Solutions during the 3rd quarter valued at $229,000. Gideon Capital Advisors Inc. bought a new stake in Medidata Solutions during the 3rd quarter valued at $263,000. Finally, Trexquant Investment LP bought a new stake in Medidata Solutions during the 3rd quarter valued at $287,000.

TRADEMARK VIOLATION NOTICE: “Insider Selling: Medidata Solutions Inc (MDSO) Director Sells $137,164.00 in Stock” was reported by WKRB News and is owned by of WKRB News. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://www.wkrb13.com/2019/01/11/insider-selling-medidata-solutions-inc-mdso-director-sells-137164-00-in-stock.html.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

See Also: What is an SEC Filing?

Insider Buying and Selling by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply